Krystal Biotech Inc (KRYS)
163.99
+0.21
(+0.13%)
USD |
NASDAQ |
May 17, 16:00
163.99
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Shares Outstanding: 28.56M for April 29, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 29, 2024 | 28.56M |
March 31, 2024 | 28.53M |
March 25, 2024 | 28.51M |
February 19, 2024 | 28.29M |
December 31, 2023 | 28.24M |
October 30, 2023 | 28.21M |
September 30, 2023 | 28.19M |
July 31, 2023 | 27.99M |
June 30, 2023 | 27.97M |
May 23, 2023 | 27.53M |
May 22, 2023 | 27.50M |
May 01, 2023 | 25.80M |
March 31, 2023 | 25.80M |
March 22, 2023 | 25.79M |
February 20, 2023 | 25.76M |
December 31, 2022 | 25.76M |
October 31, 2022 | 25.75M |
September 30, 2022 | 25.71M |
July 29, 2022 | 25.66M |
June 30, 2022 | 25.66M |
April 29, 2022 | 25.64M |
April 01, 2022 | 25.20M |
March 31, 2022 | 25.20M |
February 18, 2022 | 25.21M |
December 31, 2021 | 25.21M |
Date | Value |
---|---|
December 03, 2021 | 25.11M |
November 29, 2021 | 22.24M |
October 29, 2021 | 22.24M |
September 30, 2021 | 22.24M |
July 30, 2021 | 22.21M |
June 30, 2021 | 22.20M |
April 30, 2021 | 22.20M |
April 01, 2021 | 22.20M |
March 31, 2021 | 22.20M |
March 25, 2021 | 22.20M |
February 19, 2021 | 22.19M |
February 05, 2021 | 22.19M |
January 31, 2021 | 19.98M |
December 31, 2020 | 19.71M |
October 30, 2020 | 19.71M |
September 30, 2020 | 19.71M |
July 31, 2020 | 19.66M |
June 30, 2020 | 19.66M |
May 21, 2020 | 19.66M |
April 30, 2020 | 17.39M |
April 01, 2020 | 17.37M |
March 31, 2020 | 17.37M |
February 28, 2020 | 17.36M |
December 31, 2019 | 17.35M |
October 31, 2019 | 17.31M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
16.94M
Minimum
Jun 27 2019
28.56M
Maximum
Apr 29 2024
23.00M
Average
22.24M
Median
Sep 30 2021
Shares Outstanding Benchmarks
Axsome Therapeutics Inc | 47.50M |
Catalyst Pharmaceuticals Inc | 118.12M |
EyePoint Pharmaceuticals Inc | 52.08M |
Madrigal Pharmaceuticals Inc | 21.31M |
Viking Therapeutics Inc | 110.27M |